Research output per year
Research output per year
Personal profile
Expertises
Lymphoma research with focus on DLBCL (NGS, pathology, DH lymphoma and treatment evaluation):Immunotherapy with focus on vaccination trial in MDS patient treated with azacytidine.
Main research areas
Lymphoma; NGS; pathology;
Immunotherapy; Myelodysplastic syndrome; vaccination
Current research
Several projects:
Peptide vaccination trial (Fase 1-2) in patients with MDS and treated with azacytidine. In the same project we investigate new epitopes in MDS patients. It is in cooperation with KVL/DTU.
NGS project in regard to DLBCL in cooperation with an international research group grounded at Duke University in Durham. Furthermore in this cooperation we are gathering data to do NGS in all hematologic malignancies.
Potential conflicts of interest
In regard to our peptide-vaccination trial in MDS we have an unrestricted grant from Celgene to purchase the peptides. I have received several travel grants to meetings abroad from different companies.
Fingerprint
Dive into the research topics where Anne Ortved Gang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies
Heftdal, L. D., Hamm, S. R., Pérez-Alós, L., Madsen, J. R., Armenteros, J. J. A., Fogh, K., Kronborg, C. C., Vallentin, A. P., Hasselbalch, R. B., Møller, D. L., Hansen, C. B., Pries-Heje, M., Gang, A. O., Ostrowski, S. R., Frikke-Schmidt, R., Sørensen, E., Hilsted, L., Bundgaard, H., Iversen, K., Garred, P., & 2 others, 8 May 2023, (E-pub ahead of print) In: European Journal of Haematology.Research output: Contribution to journal › Journal article › Research › peer-review
-
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group
Ludvigsen Al-Mashhadi, A., Cederleuf, H., Kuhr Jensen, R., Holm Nielsen, T., Bjerregård Pedersen, M., Bech Mortensen, T., Relander, T., Jerkeman, M., Ortved Gang, A., Kristensen, A. L., Roost Clausen, M., de Nully Brown, P., Tang Severinsen, M., Jakobsen, L. H., Ellin, F. & El-Galaly, T. C., Mar 2023, In: American Journal of Hematology. 98, 3, p. 388-397 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Sexual dysfunction is highly prevalent in male survivors of malignant lymphoma
Micas Pedersen, S., Nielsen, T. H., Gang, A. O., Poulsen, C. B., de Nully Brown, P., Jørgensen, N., Feltoft, C. L. & Pedersen, L. M., Apr 2023, In: Sexual Medicine. 11, 2, p. qfad021Research output: Contribution to journal › Journal article › Research › peer-review
-
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study
Maksten, E. F., Jakobsen, L. H., Kragholm, K. H., Baech, J., Andersen, M. P., Madsen, J., Jørgensen, J. M., Clausen, M. R., Pedersen, R. S., Dessau-Arp, A., Larsen, T. S., Poulsen, C. B., Gang, A. O., Brown, P., Fonager, K., El-Galaly, T. C. & Severinsen, M. T., 2023, In: Clinical Epidemiology. 15, p. 337-348 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, A. O., Enggaard, L., Hansen, M., Holmström, M. O., Met, Ö., Svane, I. M., Niemann, C. U., Pedersen, L. M. & Andersen, M. H., 2022, In: Frontiers in Oncology. 12, p. 1-13 13 p., 1023015.Research output: Contribution to journal › Journal article › Research › peer-review